GGrantIndex
← Search

Core--Molecular biology

$0P30FY2000CANIH

Oregon Health And Science University, Portland OR

Investigators

Linked publications, trials & patents

Paper 39764100Paper 39763867Paper 39605535Paper 39435649Paper 39386578Paper 39375962Trial NCT07434128Trial NCT07278440Trial NCT07089940Trial NCT05705492Trial NCT04247425Trial NCT04172493Trial NCT04104139Trial NCT04061980Trial NCT04005690Trial NCT03961672Trial NCT03960177Trial NCT03699995Trial NCT03677531Trial NCT03649880Trial NCT03626285Trial NCT03613259Trial NCT03544125Trial NCT03479268Trial NCT03418025Trial NCT03406013Trial NCT03361436Trial NCT03347617Trial NCT03325166Trial NCT03280277Trial NCT03270059Trial NCT03261180Trial NCT03234309Trial NCT03135782Trial NCT03097588Trial NCT03028935Trial NCT03010358Trial NCT03009201Trial NCT02890979Trial NCT02869412Trial NCT02857218Trial NCT02779283Trial NCT02736617Trial NCT02522715Trial NCT02504359Trial NCT02503358Trial NCT02501759Trial NCT02498951Trial NCT02427841Trial NCT02359097Trial NCT02355262Trial NCT02312557Trial NCT02228265Trial NCT02100189Trial NCT02099864Trial NCT02092324Trial NCT02070705Trial NCT02050919Trial NCT01913015Trial NCT01748942Trial NCT01689987Trial NCT01649505Trial NCT01635413Trial NCT01620216Trial NCT01532687Trial NCT01498978Trial NCT01441882Trial NCT01422408Trial NCT01253642Trial NCT01031953Trial NCT01005914Trial NCT00983398Trial NCT00978562Trial NCT00900302Trial NCT00900068Trial NCT00900055Trial NCT00899795Trial NCT00899522Trial NCT00843167Trial NCT00822848Trial NCT00764517Trial NCT00722072Trial NCT00691652Trial NCT00662103Trial NCT00660543Trial NCT00659126Trial NCT00627276Trial NCT00516542Trial NCT00482274Trial NCT00425386Trial NCT00324324Trial NCT00303849Trial NCT00293475Trial NCT00253721Trial NCT00253643Trial NCT00238433Trial NCT00227682Trial NCT00103038Trial NCT00075387Patent 9279811

Abstract

The Molecular Biology Shared Resource seeks to provide the highest quality oligonucleotide synthesis and DNA sequence analysis services in a timely, convenient and cost-effective manner to support the research programs of the Cancer Center. In addition, we provide expert design, data analysis and application troubleshooting assistance. The facility currently operates one Perkin Elmer Biosystems 377 DNA sequencer and two Perkin Elmer 394 oligo synthesizers. During the last three years there has been a substantial increase in use of this shared resource reflecting the quality, convenience and value of the shared provided. Our most striking accomplishment has been the growth in utilization of our DNA sequencing services, increasing from analysis of less than 2400 templates in 1996-1997 to more than 7000 templates in the last year. Utilization of our oligonucleotide synthesis services has also steady grown with an increase from preparation of approximately 2000 oligonucleotides in 1996-1997 to synthesis of almost 2400 oligonucleotides in the last year. We have cared out a niche for this service in the university by combining highest coupling efficiency available with expert assistance with design, convenient ordering methods, and fast turnaround times. Oligonucleotides are ready for the Cancer Center member by the next morning.

View original record on NIH RePORTER →